▶ 調査レポート

試料調製の世界市場:製品別(試料調整装置、消耗品、試料調整キット、アクセサリ・付属品)、用途別(プロテオミクス、ゲノミクス、エピゲノミクス、その他)、エンドユーザー別、地域別分析

• 英文タイトル:Global Sample Preparation Market - Segmented by Product, Therapeutic Application and Geography - Growth, Trends and Forecasts (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。試料調製の世界市場:製品別(試料調整装置、消耗品、試料調整キット、アクセサリ・付属品)、用途別(プロテオミクス、ゲノミクス、エピゲノミクス、その他)、エンドユーザー別、地域別分析 / Global Sample Preparation Market - Segmented by Product, Therapeutic Application and Geography - Growth, Trends and Forecasts (2018 - 2023) / B-MOR-040837資料のイメージです。• レポートコード:B-MOR-040837
• 出版社/出版日:Mordor Intelligence / 2018年2月
• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Single User(1名様用)¥629,000 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥666,000 (USD4,500)▷ お問い合わせ
  Corporate User¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、試料調製の世界市場について調べ、試料調製の世界規模、市場動向、市場環境、製品別(試料調整装置、消耗品、試料調整キット、アクセサリ・付属品)分析、用途別(プロテオミクス、ゲノミクス、エピゲノミクス、その他)分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・試料調製の世界市場インサイト
・試料調製の世界市場環境
・試料調製の世界市場動向
・試料調製の世界市場規模
・試料調製の世界市場規模:製品別(試料調整装置、消耗品、試料調整キット、アクセサリ・付属品)
・試料調製の世界市場規模:用途別(プロテオミクス、ゲノミクス、エピゲノミクス、その他)
・試料調製の世界市場規模:エンドユーザー別
・試料調製の世界市場:地域別市場規模・分析
・試料調製の北米市場規模・予測
・試料調製のアメリカ市場規模・予測
・試料調製のヨーロッパ市場規模・予測
・試料調製のアジア市場規模・予測
・試料調製の日本市場規模・予測
・試料調製の中国市場規模・予測
・試料調製のインド市場規模・予測
・試料調製の韓国市場規模・予測
・関連企業情報・競争状況

The global sample preparation market has been estimated at around USD 3500 million in 2017 and it is expected to register a CAGR of approximately 7% during the forecast period, 2018 to 2023. North America accounted for the largest market, followed by Europe in the sample preparation market, and Asia-Pacific was estimated to register the highest growth through the forecast period, 2018-2023.

Rapid Advancements in Blood Collection Tools

Advanced technologies have reduced the number of blood vials necessary to perform blood testing. Now, hundreds of different tests can be performed from a single drop. The technology to facilitate sample collection from a central line/catheter typically involves an access device connected to the sample holder. This makes it possible to collect a sample without the use of a needle. Tasso Inc. has launched HemoLink, a painless blood collection product, for blood sampling that can be employed in broad range of diagnostic applications. There are recent technology advances in needle-safety; for e.g. needles that are manually activated after insertion into the vein. Most recent among these allow passive activation of the safety feature as the blood collection is initiated. Israel’s PixCell Medical Technologies Ltd has designed a blood count analyzer, Hemoscreen CBC for point-of-care usage, which has obtained CE mark registration of Europe. Abbott Laboratories has generated rapid growth in its small but rapidly expanding point-of-care diagnostics business, capitalizing on the desire to make diagnostics tests more accessible. Thermo Fisher has also been building its presence in the point-of-care space. Theranos CEO, Elizabeth Holmes, stated that the company has launched a blood testing platform where the device uses a finger stick to draw a microliter sample of blood into a disposable cartridge, which is loaded into the device’s “reader” for analysis; results are sent wirelessly from the reader to a secure database, from where they go online for a patient or patient’s physician to access. Besides, other factors, increase in R&D spending in the areas of life sciences and widespread adoption of automated systems will contribute to the growth of this market.

Expensive Setup Hindering the Growth of the Market

There are capital requirements for establishing advanced technologies, such as automated testing platforms. Finance for new equipment, technology license, and specialized training are the other requirements. However, acceptance of advanced technology has had profound effects on the economies of developing countries, majorly through reduced national healthcare costs. It is estimated that, 40%–50% increase in annual healthcare costs can be traced to new technologies or the intensified use of old ones. At the same time, the cost of these products has become a barrier for the growth of this market. Although there are reimbursements available for many of the diagnostic tests done, they are not affordable by the entire population. Sample preparation instruments and systems are generally expensive. The instrument cost could go as high as hundreds of thousands of US dollars depending on the technology it uses. The least expensive extraction systems available cost a few thousands of US dollars. In addition, assay reagent kits, filters, and other consumables are going to add a few hundreds of dollars more to the overall expense. The expensive instrument and assay kits are hindering the growth of the market. However, Medicaid, a program administered by individual states, but involving federal funding, is the source of medical coverage for many low-income patients in the United States. This method of reimbursement is crucial for many laboratories. The potential Medicaid reimbursement varies for services from state to state. However, these kinds of programs are offered only in developed nations. Therefore, the high cost of equipment will still act as a barrier for the market in emerging nations.

North America to Dominate the Market Growth

North America accounted for the largest market, with about 46% of the global market share. In Canada, the Canadian Blood Services (CBS) gets a provincial funding of USD 1 billion to run donor clinics, to test and distribute blood products. It is anticipated that the emerging markets with increasing population and high healthcare expenditure will have market potential.

Key Developments in the Market

• January 2018: SCIEX, a global leader in life science analytical technologies, announced the launch of its new C100HT for qualitative glycan screening in biopharmaceuticals.
• January 2018: Creative Biostructure, a standing supplier in the field of structural biology, released a guideline for its NMR sample preparation in order to make it easier for customers to understand and process its NMR service.

Major Players: Agilent Technologies, Bio-Rad Laboratories, Danaher Corporation, Illumina, Merck Millipore, Perkinelmer, Qiagen, Roche, Sigma-Aldrich, Life Technologies amongst others.

Reasons to Purchase this Report

• Current and future molecular diagnostics market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.3 Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
5.3.1 Market Drivers
5.3.1.1 Rapid Advancements in Blood Collection Tool
5.3.1.2 Increase in the R&D Spending on Life Sciences
5.3.1.3 Modern Analytical Instruments Paving the Way for Best Samples
5.3.1.4 Automated Systems Acting as an Advantage
5.3.2 Market Restraints
5.3.2.1 Expensive Setups Hindering the Growth of the Market
5.3.3 Opportunities
5.3.4 Challenges
6. Market Segmentation
6.1 By Product
6.1.1 Sample Preparation Instruments
6.1.1.1 Extraction Systems
6.1.1.1.1 Solvent Extraction
6.1.1.1.2 Solid Phase Extraction
6.1.1.1.3 Solid Phase Micro extraction
6.1.1.1.4 Supported Liquid Extraction
6.1.1.1.5 Others
6.1.1.2 Workstations
6.1.1.3 Automated Evaporation Systems
6.1.1.3.1 Evaporator Systems
6.1.1.3.2 Evaporator Sample Holders
6.1.1.3.3 Evaporator System Accessories
6.1.1.4 Liquid Handling Instruments
6.1.1.5 Others
6.1.2 Consumables
6.1.2.1 Extraction Tips
6.1.2.2 Cartridges
6.1.2.3 Plates
6.1.2.4 Columns
6.1.2.5 Dispensers
6.1.2.6 Manifolds
6.1.2.7 Tubes
6.1.2.8 Others
6.1.3 Sample Preparation Kits
6.1.3.1 Purification Kits
6.1.3.2 Isolation Kits
6.1.3.3 Extraction Kits
6.1.4 Accessories
6.2 By Application
6.2.1 Proteomics
6.2.2 Genomics
6.2.3 Epigenomics
6.2.4 Others
6.3 By End-User
6.3.1 Pharmaceuticals
6.3.2 Biotechnology
6.3.3 Molecular Diagnostics
6.3.4 Academia
6.3.5 Laboratory Diagnostics
6.3.6 Others
6.4 By Geography
6.4.1 North America
6.4.1.1 US
6.4.1.2 Canada
6.4.1.3 Mexico
6.4.2 Europe
6.4.2.1 Germany
6.4.2.2 UK
6.4.2.3 France
6.4.2.4 Italy
6.4.2.5 Spain
6.4.2.6 Rest of Europe (RoE)
6.4.3 Asia-Pacific
6.4.3.1 China
6.4.3.2 Japan
6.4.3.3 India
6.4.3.4 Australia
6.4.3.5 South Korea
6.4.3.6 Rest of Asia-Pacific
6.4.4 Middle East & Africa
6.4.4.1 GCC
6.4.4.2 South Africa
6.4.4.3 Rest of The Middle East & Africa
6.4.5 South America
6.4.5.1 Brazil
6.4.5.2 Argentina
6.4.5.3 Rest of South America
7. Competitive Landscape
7.1 Mergers & Acquisitions
7.2 Agreements, Collaborations & Partnerships
7.3 New Product Launches
8. Key Players
8.1 Agilent Technologies
8.2 Bio-Rad Laboratories
8.3 Danaher Corporation
8.4 Illumina
8.5 Merck Millipore
8.6 Perkinelmer
8.7 Qiagen
8.8 Roche
8.9 Sigma-Aldrich
8.10 Life Technologies
8.11 Others
9. Future of the Market